Brief: Procept Biorobotics Reports Q1 Revenue of USD 24.404 million
27/04/2023 12:38
Apr 27 (Reuters) - Procept Biorobotics Q1 net income USD -28.484 million. * Q1 adjusted EBITDA USD -23.918 million * Q1 revenue USD 24.404 million * Outlook FY gross margin 54% * Q1 gross margin 51%
Recent news on PROCEPT BioRobotics
See all newsU.S. STOCKS ON THE MOVE -VF Corp, Biogen, AbbVie
US STOCKS ON THE MOVE-SpaceX, Humana, AbbVie
U.S. STOCKS ON THE MOVE-SpaceX, Humana, Crescent Energy
MedTech growth concerns likely to overshadow Q3 results, Leerink says
Brief: Procept Biorobotics Corporation Enters Third Amendment To Loan And Security Agreement With Cibc